Valneva SE (EPA:VLA)
3.708
-0.068 (-1.80%)
Feb 21, 2025, 5:35 PM CET
Valneva SE Employees
Valneva SE had 676 employees as of December 31, 2023. The number of employees decreased by 43 or -5.98% compared to the previous year.
Employees
676
Change (1Y)
-43
Growth (1Y)
-5.98%
Revenue / Employee
€234,519
Profits / Employee
€10,973
Market Cap
602.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 200,000 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 10,662 |
bioMérieux | 13,982 |
Eurofins Scientific SE | 63,000 |
Ipsen | 5,325 |
Virbac | 5,459 |
emeis Société anonyme | 77,954 |
Valneva SE News
- 4 days ago - Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook - GlobeNewsWire
- 16 days ago - Valneva rises after U.K. approval of chikungunya vaccine - Seeking Alpha
- 17 days ago - Valneva Receives Marketing Authorization in the UK for the World's First Chikungunya Vaccine, IXCHIQ® - GlobeNewsWire
- 22 days ago - Valneva wins new U.S. contract for Japanese encephalitis vaccine, Ixiaro - Seeking Alpha
- 23 days ago - Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million - GlobeNewsWire
- 4 weeks ago - Valneva Is A 'Buy' As A First-Mover In Chikungunya - Seeking Alpha
- 4 weeks ago - Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision - GlobeNewsWire
- 4 weeks ago - Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot - Benzinga